The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Session ID: 2025-06-24:936f947c98ce6f73831a607 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...

Next up, there were some updates from the FDA about a new RSV vaccine for infants and a new treatment for gonorrhea. Andrea, tell us more about both of those. Garcia: So last week, the FDA approved a ...

It may reduce RSV infection rate by 67% at two years’ follow-up. Palivizumab also reduces the number of wheezing days by 61% but may result in little to no difference in days using oxygen, length of ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young children, placing a significant burden on families, hospitals, and the healthcare system. Recent ...

This episode focused on the most pressing unmet needs in RSV prevention and the clinical impact of newly approved options. Tan highlighted a key issue from the initial rollout of nirsevimab: supply ...

Flu, COVID-19, and Respiratory Syncytial Virus (RSV): If you are ill with a respiratory virus, PLEASE STAY HOME and away from others. This will help everyone. If you are in the clinical portion of ...

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...